|
DNAJC5 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.87970000001359E-06 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.32010000000837E-06 |
| Normal-vs-Stage2 |
4.806400E-01 |
| Normal-vs-Stage3 |
4.59320000001373E-06 |
| Normal-vs-Stage4 |
1.31999999997134E-06 |
| Stage1-vs-Stage2 |
7.586800E-04 |
| Stage1-vs-Stage3 |
6.371200E-01 |
| Stage1-vs-Stage4 |
1.949370E-01 |
| Stage2-vs-Stage3 |
1.062050E-03 |
| Stage2-vs-Stage4 |
4.801900E-04 |
| Stage3-vs-Stage4 |
3.846800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.97599999982334E-07 |
| Normal-vs-AfricanAmerican |
3.047600E-02 |
| Normal-vs-Asian |
2.43580000000021E-05 |
| Caucasian-vs-AfricanAmerican |
3.262200E-01 |
| Caucasian-vs-Asian |
9.878000E-01 |
| AfricanAmerican-vs-Asian |
3.895400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.766500E-04 |
| Normal-vs-Female |
9.43330000002796E-07 |
| Male-vs-Female |
2.553600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.2714000003663E-07 |
| Normal-vs-Age(41-60Yrs) |
3.87699999999658E-05 |
| Normal-vs-Age(61-80Yrs) |
4.901800E-03 |
| Normal-vs-Age(81-100Yrs) |
2.212600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.364600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.683900E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.379200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.705400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.689400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.880000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.371090E-04 |
| Classical-VS-Follicular |
1.440500E-04 |
| Classical-VS-Other |
1.587220E-01 |
| Classical-VS-Normal |
2.30279999957617E-07 |
| Tall-VS-Follicular |
5.54659995710693E-09 |
| Tall-VS-Other |
8.215200E-01 |
| Tall-VS-Normal |
2.2825996648379E-10 |
| Follicular-VS-Other |
1.582790E-03 |
| Follicular-VS-Normal |
3.754800E-01 |
| Other-VS-Normal |
1.539770E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.361700E-03 |
| Normal-vs-N1 |
1.1720002746074E-10 |
| N0-vs-N1 |
1.40329999953615E-07 |
|
|
